retatrutide triple agonist glp-1 gip glucagon #retatrutide is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter https://t.co/duYwW0EcmF How Does Retatrutide Work? The

This study aimed to quantify temporal trends in GLP-1 RA initiation rates specifically for weight management among eligible adults without diabetes within a large Polish private healthcare network, examining uptake patterns and estimating the national burden of the unmet need in this challenging financial landscape

GS: Methodology, Validation, Writing original draft, Writing review & editing

The half-life can usually be approximated at 80 hours, unless it is known (from pharmacokinetic calculation)

272 Interrogation of stem-cell derived organoids and organotypic slice cultures revealed preferential infection of astrocytes with SARS-2

2020 Sep 15;13(9):247